Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study.

Tagrisso (osimertinib) - AstraZeneca

Semena (befotertinib) - InventisBio, Betta Pharma

erlotinib - Generic mfg.

Rui Bi Da (rezivertinib) - Beta Pharma

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Lazcluze (lazertinib) - J&J

Tabrecta (capmatinib) - Novartis

BI-4020 - Boehringer Ingelheim

Ivesa (firmonertinib) - Allist, ArriVent

http://www.ncbi.nlm.nih.gov/pubmed/39061985

Akira Hamada; Hana Oiki; Junichi Soh; Kenichi Suda; Masaoki Ito; Shota Fukuda; Shuta Ohara; Tetsuya Mitsudomi; Yasuhiro Tsutani

Jul 27, 2024